Profil épidémiologique et clinique, et survie à 90 jours des patients incidents en hémodialyse chronique au cours de la pandémie à SARS-CoV2 au Cameroun : expérience de l’hôpital général de Douala (notice n° 759905)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04502cam a2200349 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250123102016.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Fouda Menye Epse Ebana, Hermine Danielle |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Profil épidémiologique et clinique, et survie à 90 jours des patients incidents en hémodialyse chronique au cours de la pandémie à SARS-CoV2 au Cameroun : expérience de l’hôpital général de Douala |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2021.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 62 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | IntroductionL’impact de la pandémie à COVID-19 sur les malades rénaux chroniques en instance de dialyse en Afrique sub-saharienne est inconnu. L’objectif de cette étude est de décrire le profil épidémio-clinique et la survie à court terme des patients incidents en hémodialyse chronique au cours de la pandémie à COVID-19 au Cameroun. Matériel et méthodeNous avons conduit une cohorte prospective de 6 mois incluant tous les patients incidents en hémodialyse chronique à l’hôpital général de Douala, d’avril à octobre 2020. Les patients avec une infection suspectée ou confirmée à SARS-CoV2 étaient identifiés comme COVID-19. Nous nous sommes intéressés aux données socio-démographiques, cliniques et biologiques à l’admission en dialyse, et à la mortalité dans les 9 jours. RésultatsAu total, 57 patients incidents ont été enregistrés, soit une moyenne mensuelle de 9,5 patients. La moyenne d’âge était de 46,9±13,1 ans. Vingt-quatre patients (42 %) avaient une COVID-19 (49 % des dialyses en urgence). L’œdème aigu du poumon (79,2 % vs 42,4 % ; p=0,006) et l’encéphalopathie urémique (83,4 % vs 53,6 % ; p=0,022) étaient plus fréquents au cours de la COVID-19 comparés aux patients non COVID-19. La survie globale à 90 jours était de 49 %, avec une tendance plus faible chez les patients COVID-19 et ceux ayant un faible niveau socio-économique. En régression de Cox, le risque de décès instantané augmentait de 3,08 en cas de niveau socio-économique faible. ConclusionL’infection à SARS-CoV2 est associée à une tendance à la majoration des urgences et de la mortalité à court terme en dialyse dans notre contexte. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | BackgroundThe effect of COVID-19 pandemic on end stage renal disease patient who should initiated dialysis are limited in Sub-Saharan Africa is unknown. We sought to describe the epidemiologic and clinical profile of newly admitted patient in chronic haemodialysis during the COVID-19 pandemic in Cameroon and evaluate their survival between 90days of dialysis initiation. Material and methodWe conducted a cohort study of 6months from April to October 2020. End stage renal disease patients newly admitted in the haemodialysis facility of the General Hospital of Douala were included. Patients with confirmed or suspected COVID-19 were identified. Socio-demographic, clinical and biological data at dialysis initiation as well as mortality between the 90days of dialysis initiation were registered. ResultsA total of 57 incident patients were recorded from April to October 2020 with a monthly mean of 9.5 patients. The mean age was 46.95±13.12years. Twenty-four COVID-19 were identified with a frequency of 49% among emergency admission. Pulmonary œdema (79.2% vs. 42.4%; P=0.006) and uremic encephalopathy (83.4% vs. 53.6%; P=0.022) were more common in COVID-19. The overall survival at 90days was 48% with a tendency to poor survival among COVID-19 and patients with low socioeconomic level. In Cox regression, low socioeconomic level increase the risk of instant death by 3.08. ConclusionSARS-CoV2 seem to increase nephrology emergency and poor survival in haemodialysis at 90days. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | COVID-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Patient incident |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Survie à court terme |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Niveau socio-économique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Hémodialyse chronique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Survival at 90 days |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | COVID-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Chronic haemodialysis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Socioeconomic level |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Incident patient |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Halle, Marie-Patrice |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mbele Onana, Charles |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mbatchou, Bertrand Hugo |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Luma Namme, Henry |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ashuntantang Enow, Gloria |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Néphrologie & Thérapeutique | Volume 17 | 4 | 2021-04-26 | p. 226-232 | 1769-7255 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-nephrologie-et-therapeutique-2021-4-page-226?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-nephrologie-et-therapeutique-2021-4-page-226?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux